{
    "paper_id": "cdf7bfd05e870b7fe7be6a88016ea9bd2f192c42",
    "metadata": {
        "title": "Journal Pre-proof Impacts of COVID-19 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-based Study Impacts of COVID-19 Pandemic on Gastrointestinal Endoscopy Volume and Diagnosis of Gastric and Colorectal Cancers: A Population-based Study Subtitle: COVID-19 and diagnosis of gastrointestinal cancers",
        "authors": [
            {
                "first": "Thomas",
                "middle": [
                    "Kl"
                ],
                "last": "Lui",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Kathy",
                "middle": [],
                "last": "Leung",
                "suffix": "",
                "affiliation": {
                    "laboratory": "WHO Collaborating Centre for Infectious Disease Epidemiology and Control",
                    "institution": "The University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Chuan-Guo",
                "middle": [],
                "last": "Guo",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Vivien",
                "middle": [
                    "Wm"
                ],
                "last": "Tsui",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Joseph",
                "middle": [
                    "T"
                ],
                "last": "Wu",
                "suffix": "",
                "affiliation": {
                    "laboratory": "WHO Collaborating Centre for Infectious Disease Epidemiology and Control",
                    "institution": "The University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": ""
            },
            {
                "first": "Wai",
                "middle": [
                    "K"
                ],
                "last": "Leung",
                "suffix": "",
                "affiliation": {
                    "laboratory": "",
                    "institution": "University of Hong Kong",
                    "location": {
                        "settlement": "Hong Kong SAR",
                        "country": "China"
                    }
                },
                "email": "waikleung@hku.hkfax:85228162863"
            }
        ]
    },
    "abstract": [],
    "body_text": [
        {
            "text": "The coronavirus disease (COVID-19) pandemic has caused a major disruption to our healthcare system. In response to the service demand surge and shortage of personal protective equipment, multiple professional societies have issued recommendation to defer elective endoscopic procedures, except time-sensitive and emergency procedures. [1] [2] [3] As yet, the real-life impact of this pragmatic service reduction is unknown. Herein, we reported the short-term impacts of the COVID-19 pandemic on the volume of gastrointestinal endoscopy and new diagnosis of gastric and colon cancers in Hong Kong, and modelled on the changes in cancer staging.",
            "cite_spans": [
                {
                    "start": 335,
                    "end": 338,
                    "text": "[1]",
                    "ref_id": null
                },
                {
                    "start": 339,
                    "end": 342,
                    "text": "[2]",
                    "ref_id": null
                },
                {
                    "start": 343,
                    "end": 346,
                    "text": "[3]",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "INTRODUCTION"
        },
        {
            "text": "The first local COVID-19 case was reported on 23 January 2020 and till May 8 2020, a total and 58.8% (from 1190 to 491, p<0.001), respectively. The mean gastric cancer and colorectal cancer diagnosed per week also fell by 46.2% (from 22.9 to 12.3, p < 0.001) and 37.0% (from 92.1 to 58, p<0.001), respectively. Notably, the positive rates (per 1,000 endoscopy) for gastric cancer remained static throughout these periods (11.8 to 13.9, p =0.14; Supplementary For gastric cancer, the ARIMA(0,1,1)(1,0,1) 26 model with a 26-week cyclical pattern was fitted with data from previous years. The mean percentage error (MPE) of the model was 2.5% and 3.5% for the training set and test set, respectively. For colorectal cancer, the MPE of the ARIMA(0,0,1)(1,0,1) 26 model was 2.8% and 3.3%, respectively. For the 10-week period starting from 21 January 2020, the predicted number of gastric cancer and colorectal cancer ",
            "cite_spans": [],
            "ref_spans": [],
            "section": "METHODS"
        },
        {
            "text": "This is the first study to quantify the disruption brought by the COVID-19 pandemic on the delivery of gastrointestinal endoscopy and its impacts on cancer diagnosis and staging at a population level. While the volume of endoscopy was reduced by more than 50% in Hong Kong, the number of patients diagnosed with gastric and colorectal cancer dropped by 49.1% and 38.1%, respectively. Based on the ARIMA prediction and Markov model, we estimated that 4.6% and 6.4% of gastric and colorectal patients would have cancer stage upshifting at 6 months.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "In a recent report from a single hospital in Shanghai China, it was noted that their endoscopy volume dropped by 6.3-times during COVID-19 6 . In another North American survey, 65% of centers were performing less than 10% of their usual volume 7 . However, public hospitals in Hong Kong do not routinely perform screening endoscopy and the potential impacts on delayed cancer diagnosis could be worse than centers that primarily performed screening procedures.",
            "cite_spans": [
                {
                    "start": 139,
                    "end": 140,
                    "text": "6",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "Interestingly, we noted that the impact of service reduction on upper endoscopy was more critical than lower colonoscopy as the positive rate for cancer by lower colonoscopy actually increased after the outbreak, suggesting that triage based on lower gastrointestinal symptoms is more reliable than upper gastrointestinal symptoms in arranging early endoscopy.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "In conclusion, the COVID-19 outbreak has resulted in substantial drop in endoscopy services in Hong Kong, which is associated with significant delay on cancer diagnosis. The delay and subsequent cancer stage upshifting will be amplified if the COVID-19 pandemic lengthens further. Gradual resumption of non-emergency endoscopy services should be considered as early as feasible and practical, balancing the risks of delayed cancer diagnosis and personal safety of patients and staff. Shading area and error bars represented 95% confidence intervals.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "DISCUSSION"
        },
        {
            "text": "We analyzed the numbers of upper and lower endoscopy performed; and the number of new cases of gastric cancer and colorectal cancer diagnosed between 1 October and 31 March in each year on a weekly basis. Buishand U test was used to determine the week of turning point of the sudden changes in the numbers of endoscopy performed and the numbers of cancer diagnosed (i.e. week of turning point). The mean number of endoscopies performed and the mean number of cancers diagnosed per week were compared by two sample t-test before and after the turning point. Pearson correlation was used to assess for any association between the number of cancers diagnosed and the volume of endoscopy. The test set started from 1 Oct 2019 to the week of turning point as determined by the Buishand U test for internal and external validation of the model. The mean percentage error (MPE) were used to test the accuracy of the forecast. Based on the numbers of new diagnosis of gastric or colorectal cancer before the week of turning point as determined by the Pettitt's test, ARMIA prediction of the numbers of patients diagnosed with gastric or colorectal cancer was made. The weekly-based data after excluding the lunar new year holiday effect was used in the ARIMA prediction. The difference between the ARIMA prediction and actual number of patients diagnosed with gastric cancer or colorectal cancer were used to estimate the number of patients with delayed cancer diagnosis after the turning point.",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Time trend analysis of newly diagnosed gastric and colorectal cancers during COVID-19"
        },
        {
            "text": "The baseline stage distribution of colorectal cancer in Hong Kong was: stage I (11.0%), stage II (21.9%), stage III (25.9%), stage IV (23.5%) and unstaged (17.7%) 1 , respectively. The corresponding stage distribution of gastric cancer was: stage I (11.8%), stage II (27.1%), stage III (18.6%), stage IV (30.5%) and unstaged (16.3%).",
            "cite_spans": [],
            "ref_spans": [],
            "section": "Prediction of Cancer Stage Shifting at Diagnosis"
        },
        {
            "text": "Based on currently available data for gastric cancer, the annual transition rate from stage I to II was 0.20, stage II to III was 0.30 and stage III to IV was 0.40. 2 For colorectal cancer, the annual transition rate for colorectal cancer from stage I to II was 0.58, stage II to III was 0.66 and stage III to IV was 0.83. 3 The potential stage shifting of these cancers with delayed diagnosis were estimated by using a state-transition Markov model. Linear regression models were formulated for the association between upper endoscopy volume and numbers of newly diagnosed gastric cancer; and between lower endoscopy volume and numbers of newly diagnosed colorectal cancer.",
            "cite_spans": [
                {
                    "start": 165,
                    "end": 166,
                    "text": "2",
                    "ref_id": null
                },
                {
                    "start": 323,
                    "end": 324,
                    "text": "3",
                    "ref_id": null
                }
            ],
            "ref_spans": [],
            "section": "Prediction of Cancer Stage Shifting at Diagnosis"
        }
    ],
    "bib_entries": {
        "BIBREF7": {
            "ref_id": "b7",
            "title": "Hospital Authority. Hong Kong Cancer Registry",
            "authors": [],
            "year": null,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": "",
            "other_ids": {}
        }
    },
    "ref_entries": {
        "FIGREF0": {
            "text": "of 1,045 cases were reported. The total numbers of upper and lower endoscopy performed in all public hospitals in Hong Kong between 1 October 2019 and 31 March 2020, and from the same period in the preceding three years, were retrieved by the Clinical Data Analysis and Reporting System (CDARS) of the Hong Kong Hospital Authority. Cancer diagnosis was verified by the Anatomical Pathology Database of the CDARS system. 4-5 Autoregressive integrated moving average (ARIMA) model was used to predict the trend of patients newly diagnosed with gastric or colorectal cancers with Buishand U test to determine the week of turning point of the sudden changes. A linear regression model was constructed to assess the relationship between the number of cancers diagnosed and the volume of endoscopy. The potential stage shifting of these cancers with delayed diagnosis were estimated by using a state-transition Markov model (Supplementary material). The study was approved by the Institutional Review Board of the University of Hong Kong and the Hong Kong West Cluster of Hospital Authority, Hong Kong (reference no: UW 20-279).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF1": {
            "text": "The number of procedures performed and the number of cancers diagnosed in the study period were shown in Supplementary Table 1. The Buishand U test showed a turning point in the number of upper and lower endoscopy performed (p<0.001) and the number of gastric and colorectal cancers diagnosed (p<0.001) during the week of 21-27 January, when the first local COVID-19 case was diagnosed. From that week onwards, the mean number of upper and lower endoscopy performed per week dropped by 51.0% (from 1813 to 887, p<0.001)",
            "latex": null,
            "type": "figure"
        },
        "FIGREF2": {
            "text": "was higher than observed by 51.1%, (221, 95%CI: 136-357 vs 123, p<0.01) and 32.9% (865, 95%CI: 668-1286 vs 580, p<0.01), respectively (Figure 1). Based on Markov model prediction, 4.6% of gastric cancer and 6.4% of colorectal cancer patient would have higher stage shifting at 6-month. In particular, the proportion of stage IV cancers increased (gastric: 30.5% to 32.4%, p<0.01and colorectal: 23.5% to 26.8%, p<0.01). Linear regression model showed a linear relationship between the numbers of gastric cancer and upper endoscopy volume; and between the numbers of colorectal cancer ). If there is a further 20% reduction in current endoscopy volume, the corresponding mean number of gastric cancers and colorectal cancer diagnosed per week would fall by 54.1% (10.5 vs 22.9) and 41.1% (54.0 vs 91.7) from baseline. With 20% more reduction in endoscopy services, the predicted proportion of gastric and colorectal cancer patients with stage upshifting was 5.3% (vs current 4.6%) and 7.2% (vs current 6.4%) at 6 months (Supplementary Figure 1).",
            "latex": null,
            "type": "figure"
        },
        "FIGREF3": {
            "text": "Panels : Actual versus predicted numbers (by ARIMA) of endoscopy and cancers diagnosed per week. Left: Gastric cancer; Right: Colorectal cancer Lower: Prediction on changes in cancer staging with various durations of COVID-19 outbreak in Hong Kong. Left: Gastric cancer; Right: Colorectal cancer",
            "latex": null,
            "type": "figure"
        },
        "FIGREF4": {
            "text": "Autoregressive integrated moving average (ARIMA) was used to predict the trend of patients diagnosed with gastric or colorectal cancers. The corrected Akaike's information Criterion(AICc) was used to choose the ARIMA models with different parameters combination. The weekly data were split into different training sets from 1 Oct 2016 to 31 March 2017, from 1 Oct 2017 to 31 March 2018, and from 1 Oct 2018 to 31 March 2019. The training data were first used to fit the model with adjustment of holiday effect of Christmas and Lunar new year.",
            "latex": null,
            "type": "figure"
        },
        "TABREF0": {
            "text": "but increased for colorectal cancer (75.6 to 118.2, p<0.001).",
            "latex": null,
            "type": "table"
        }
    },
    "back_matter": [
        {
            "text": "All statistical analyses were performed by the R statistical software (version 3.2.3; R Foundation for Statistical Computing). Continuous variables were expressed as median and interquartile range (IQR). The Mann-Whitney U-test was used to compare continuous variables between two groups. The Chi-square test or Fisher's exact test, where appropriate, was applied for comparing categorical variables",
            "cite_spans": [],
            "ref_spans": [],
            "section": "acknowledgement"
        }
    ]
}